salesforce.com Stock Buy or Sell? CRM Stocks Forecast

Market Capitalization: 283 430 388 000 $
EBITDA: 8 476 000 000 $
Price to Earnings: 110.91
Quarterly Earnings Growth YOY: 4.952
Quarterly Revenue Growth YOY: 0.113
Trailing PE: 110.91
Forward PE: 30.58
Shares Outstanding: 968000000






Trading Penny Stocks for Profit: Expert Insights and Practical Advice

February 22, 2024 Trading Penny Stocks for Profit: Expert Insights and Practical Advice

For aspiring traders and seasoned investors alike, the enticing appeal of penny stocks can be likened to voyaging across the vast oceans, discovering…
Getting A Kredittkort Norge Approval Isn’t Difficult

February 8, 2024 Getting A Kredittkort Norge Approval Isn’t Difficult

If you meet the conditions, you can open an account for checking in Norway. However, it will be much easier and more convenient…
How to Understand Social Security: 6 Legal & Financial Tips

January 25, 2024 How to Understand Social Security: 6 Legal & Financial Tips

Understanding social security can seem overwhelming, but it’s an important part of financial planning, particularly for retirement. The following 6 legal and financial…
Finding Energy Plans with Billig Strøm Rates

January 10, 2024 Finding Energy Plans with Billig Strøm Rates

It can be overwhelming to decide on the best plan when in a state where electricity is deregulated. The number of providers is…

salesforce.com Stock Buy or Sell? CRM Stocks Analytic Forecasts

Updated on February 27, 2024 (10:19)

salesforce.com, inc. (CRM prediction charts) Sector: Technology

We present you the most up-to-date and complete review of analytical trend forecasts and views on the CRM stock market. Experts share their opinions on what to expect from the salesforce.com, inc. stock market. How likely is the stock price to move in a bullish or bearish trend. Which should help you to make the right decision whether to Buy or Sell salesforce.com stocks.

salesforce.com, inc. Stock Market Experts’ Analysis and Forecasting – Sell or Buy CRM Shares?

The most recent analytical view which can help you to answer the worrying question: Should I Buy Stocks Now or Wait? came out under the authorship of Oliver Rodzianko and is titled

“Salesforce: Valuation Risk Might Be Offset By Einstein AI”

is published on February 15 (2024) and has 0 likes. The review predicts Bullish market trend.

It summarize the following theses:

  • Salesforce’s Einstein AI technology enhances the Customer Success Platform, offering personalization, better decision-making, and higher efficiency.
  • The global AI in retail market is expected to have a high CAGR over the next decade, contributing to CRM’s revenue growth.
  • Salesforce’s strong balance sheet and internal efficiencies make it well-positioned for long-term growth, but valuation risk is a concern.
  • Primarily due to the significant opportunity in the fast-growing AI market, my analyst rating for CRM stock is a Buy.

The author starts his analytic review with the following:

Salesforce (NYSE:CRM) is one of the most compelling investments to make for exposure to AI at this time, particularly for retail applications. It is tempting to totally ignore the valuation risk based on the exceptional results so far and the expected high market growth in the future. However, we must be aware of market risks, as over-allocating to CRM could prove costly.

The author declares an interesting position, and the number of his followers is 363 and it grows, but not that weighty compared to other authors.
Oliver Rodzianko has 41 works published.
The contributor of experts community since 2023


One more noteworthy article is written by Jim Sloan under the title

“Salesforce: Improving Profit Margins Come With A Backstory”

on January 30 (2024) and has 0 likes. The expert reflects Strong Bullish trend of the market.

Нis theses make you think about whether to add CRM stocks to your investment portfolio or not, and helps to work out your own salesforce.com stock selling strategies:

  • Salesforce has many qualities of a brilliant growing blue chip, ranked number one in enterprise software and number three in software with a huge Total Addressable Market.
  • In early 2023 activist hedge funds threatened Salesforce on the grounds of insufficient profitability, too much emphasis on growth alone, too many acquisitions, and excessive expenditures.
  • Salesforce succeeded in lifting profit margins by severe cost cutting but must maintain a proper balance for long term success.

Jim Sloan starts analysis with such words:

Salesforce (NYSE:CRM) is the number one enterprise software company with a 22% share of the market followed by MSFT (MSFT) at 5.7% and Oracle (ORCL) at 4.7%. It is also the number three software company, in this category trailing Microsoft and Oracle. Though number one in the category it dominates it clearly has plenty of room to expand. It has an estimated Total Addressable Market with a self-generated figure of $290 billion by 2026. Trailing Q3 2023 (2024 FY) revenues were about $34 billion. That’s only 11.7% of the 2026 number which is itself up from the year ago $204 forecast of TAM for 2025. Current Remaining Performance Obligations increased by 14% to $23.9 billion in 2023 while long term RPOs increased by 21% to $48.3 billion non-cancellable contractual obligations. That’s the number combining Deferred Revenue and Backlog required under Accounting Standards Codification 606 starting in 2018, as provided here in the Q3 Salesforce report. It is a number useful to SaaS businesses in showing tangible evidence of momentum and success in acquiring long term contracts.

This author is very popular among the auditory. He has 19881 followers

Jim Sloan is the contributor of experts community since 2013. Has published at least 263 articles.


Another analysis presented by Julian Lin came out on January 26 (2024). Obviously, coupled with the newer reviews, this forecasting could be useful to find out the best trading strategy for CRM stocks. It sounds like

“Salesforce: Net Cash, Share Repurchases, Growing Margins, GARP Valuation”

Article has got 0 likes at the moment and forecasting Bullish trend of the market.

Summarizing the information presented in the review concerning the salesforce.com, inc., the expert says the following:

  • Salesforce is on a path to become the next Microsoft, with a wide and deep product portfolio and a commitment to driving profitable growth.
  • The company showed strong cRPO growth in the latest quarter.
  • While top-line growth may slow, I expect investors to reward the stock for its resilient business model and growing profitability.
  • Salesforce remains a GARP stock for the long term.

And here, what comes first:

I am growing increasingly convinced that Salesforce, Inc. (NYSE:CRM) is on a path to become the next Microsoft Corporation (MSFT). Specifically, CRM has assembled a wide and deep product portfolio and has demonstrated a strong commitment to driving profitable growth. The company maintains a net cash balance sheet and has shown incredible operating margin expansion. While top line growth looks poised to slow moving forward, I expect the market to continue rewarding the stock for the commitment to profitability. Over time, I see CRM sustaining a premium valuation similar to MSFT as investors begin prioritizing consistent profits and share repurchases over revenue growth rates.

This author is very popular among the auditory. He has 31872 followers.

Julian Lin is the contributor of experts community since 2017 and has at least 1040 analytic reviews published.


The Share Price of salesforce.com, inc. (CRM) for now

What analysts predict: $294.22
52-week high/low: $303.83 / $161.53

50/200 Day Moving Average: $274.25 / $229.74

The average stock price over the previous 50/200 days. For salesforce.com stocks, the 50-day moving average is the resistance level for now. For CRM stocks, the 200-day moving average is the resistance level today.

See the Detailed Predictions for CRM stock with charts and tables

Related Analysis

View all analytics

Micron: Memory Market Recovery Fast-Tracked

Buy or Sell MU shares? Micron: Memory Market Recovery Fast-Tracked
April 20, 2023
A lot has happened since our last note on Micron; reports of weaker data center capex spending, the CAC announcing its investigation, and Samsung pledging to cut memory chip production.

Apple: Poised To Continue Disrupting Our Lifestyles

Buy or Sell AAPL shares? Apple: Poised To Continue Disrupting Our Lifestyles
February 10, 2024
Apple continues demonstrating massive resilience with revenue demonstrating growth and EPS expanding despite navigating challenging environment.

Texas Instruments: Worth Investing In For Long-Term Investors

Buy or Sell TXN shares? Texas Instruments: Worth Investing In For Long-Term Investors
February 9, 2024
Texas Instruments Incorporated is facing continued weak demand for its chips, resulting in a decline in revenue and a soft outlook for 2024.

Unity Software: 2024 Will Be A Show-Me Year (Rating Downgrade)

Buy or Sell U shares? Unity Software: 2024 Will Be A Show-Me Year (Rating Downgrade)
February 12, 2024
I am skeptical about Unity Software's ability to achieve the touted $1 billion EBITDA in 2024, prompting a revision to a sell rating.